Former Abbott, Melinta Exec Steps into Head Seat at Aegerion

Xconomy Boston — 

Mary Szela has been named the CEO of Cambridge, MA-based Aegerion Pharmaceuticals (NASDAQ: AEGR). Szela replaces Sandford Smith, who has been Aegerion’s interim CEO since Marc Beer resigned in July. She’s coming off a stint as CEO of Melinta Therapeutics, and spent more than a decade at Abbott Laboratories before that. Smith, meanwhile, will serve as Aegerion’s chairman going forward.